Skip to content

A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers (The ARREST Study)

A Prospective, Multicenter, Randomized Control Study To Determine Clinical Effectiveness, Patient Wellness and Cost of Pain Related Care of In-Elastic Lumbar Sacral Orthoses Versus Standard Medical Treatment in Patients Presenting With Acute Low Back Pain In Primary Care Centers

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03100097
Acronym
ARREST
Enrollment
62
Registered
2017-04-04
Start date
2013-12-16
Completion date
2017-12-31
Last updated
2018-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Low Back Pain

Brief summary

The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.

Detailed description

The objective of this study is to evaluate sixty male and non-pregnant female patients diagnosed with acute moderate to severe low back pain with the onset of symptoms within 30 days. To evaluate functional improvement following a 4-week use of an in-elastic lumbar sacral orthosis (LSO) as a treatment modality for acute low back pain.

Interventions

DEVICEAspen Horizon 627 LSO

Sponsors

Aspen Medical Products
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion Criteria: o Moderate to complete disability (baseline ODI score of 21 to 80 percent) *

Exclusion criteria

* Pregnant patients * Patients considering pregnancy * Patients in any other investigational device or drug study * Patients unwilling to return for follow up * Patients unwilling to provide access to medical claims associated with pain management.

Design outcomes

Primary

MeasureTime frameDescription
40% change in Oswestry Disability Index4 weeksOswestry Disability Index

Secondary

MeasureTime frameDescription
Change in Opioid utilization4 weeks, 8 weeks, 12 weeksChange in Opioid utilization
Number of participants with treatment-related adverse events as assessed by questionnaire4 weeks, 8 weeks, 12 weeksWere any complications associated wearing of the brace noted in patients questionnaires
General Health Survey12 weeksSF36v2 Health Survey

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026